By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Navidea Biopharmaceuticals 

425 Metro Place Northurt
Suite 400
Dublin  Ohio  43017  U.S.A.
Phone: 614-793-7500 Fax: 614 793 7520


Medical Device

Company News
Navidea (NAVB) To Present At Sidoti Emerging Growth Conference 8/25/2015 8:46:17 AM
Navidea (NAVB) To Register Shares For Dual Listing On Tel-Aviv Stock Exchange 8/24/2015 9:25:33 AM
Navidea (NAVB) Reports Publication Of Lymphoseek Comparative Results In Injection Site Pain Study In Breast Cancer 8/20/2015 8:49:02 AM
Navidea (NAVB) Reports Second Quarter 2015 Financial Results; Reiterates 2015 Lymphoseek Revenue Guidance 7/30/2015 1:19:11 PM
Navidea (NAVB) Awarded $1.7 Million Fast Track NIH SBIR Grant For Evaluation Of Manocept In Rheumatoid Arthritis 7/29/2015 11:08:30 AM
Navidea (NAVB) And Massachusetts General Hospital To Evaluate Manocept For Detection Of Cardiovascular Disease With NIH Grant 7/28/2015 10:37:04 AM
Navidea (NAVB) To Announce Second Quarter 2015 Financial Results On July 30, 2015 7/23/2015 10:58:52 AM
Navidea (NAVB) Release: Verification Of Lymphoseek Mechanism Of Action Published In Journal Of Immunology 7/23/2015 10:41:13 AM
Navidea (NAVB) Announces 2015 Annual Meeting Results 7/17/2015 7:39:25 AM
Navidea (NAVB) And Macrophage Therapeutics To Host Post-International KSHV Conference Summary Webcast / Call 7/7/2015 10:13:40 AM